These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 28604741)

  • 1. A novel nuclear complex of DRR1, F-actin and COMMD1 involved in NF-κB degradation and cell growth suppression in neuroblastoma.
    Mu P; Akashi T; Lu F; Kishida S; Kadomatsu K
    Oncogene; 2017 Oct; 36(41):5745-5756. PubMed ID: 28604741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DRR1 is expressed in the developing nervous system and downregulated during neuroblastoma carcinogenesis.
    Asano Y; Kishida S; Mu P; Sakamoto K; Murohara T; Kadomatsu K
    Biochem Biophys Res Commun; 2010 Apr; 394(3):829-35. PubMed ID: 20298674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
    Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
    Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMMD1 regulates cell proliferation and cell cycle progression by modulating p21 Cip1 levels.
    Jiang Z; Yuan Y; Zheng H; Cui H; Sun X; Zhao W; Liu X
    Biosci Biotechnol Biochem; 2019 May; 83(5):845-850. PubMed ID: 30667321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Stress-Inducible Protein DRR1 Exerts Distinct Effects on Actin Dynamics.
    Kretzschmar A; Schülke JP; Masana M; Dürre K; Müller MB; Bausch AR; Rein T
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30545002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression.
    Chen L; Mu B; Li Y; Lu F; Mu P
    Pediatr Res; 2023 Mar; 93(4):852-861. PubMed ID: 35854089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of COMMD1 by miR-205 promotes a positive feedback loop for amplifying inflammatory- and stemness-associated properties of cancer cells.
    Yeh DW; Chen YS; Lai CY; Liu YL; Lu CH; Lo JF; Chen L; Hsu LC; Luo Y; Xiang R; Chuang TH
    Cell Death Differ; 2016 May; 23(5):841-52. PubMed ID: 26586569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.
    Taura M; Kudo E; Kariya R; Goto H; Matsuda K; Hattori S; Vaeteewoottacharn K; McDonald F; Suico MA; Shuto T; Kai H; Okada S
    J Virol; 2015 Mar; 89(5):2643-58. PubMed ID: 25520503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase.
    Maine GN; Mao X; Komarck CM; Burstein E
    EMBO J; 2007 Jan; 26(2):436-47. PubMed ID: 17183367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear-cytosolic transport of COMMD1 regulates NF-kappaB and HIF-1 activity.
    Muller PA; van de Sluis B; Groot AJ; Verbeek D; Vonk WI; Maine GN; Burstein E; Wijmenga C; Vooijs M; Reits E; Klomp LW
    Traffic; 2009 May; 10(5):514-27. PubMed ID: 19220812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
    Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
    Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer.
    Fedoseienko A; Wieringa HW; Wisman GB; Duiker E; Reyners AK; Hofker MH; van der Zee AG; van de Sluis B; van Vugt MA
    PLoS One; 2016; 11(10):e0165385. PubMed ID: 27788210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of COMMD protein-protein interactions in NF-kappaB signalling.
    de Bie P; van de Sluis B; Burstein E; Duran KJ; Berger R; Duckett CS; Wijmenga C; Klomp LW
    Biochem J; 2006 Aug; 398(1):63-71. PubMed ID: 16573520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The stress-inducible actin-interacting protein DRR1 shapes social behavior.
    Masana M; Su YA; Liebl C; Wang XD; Jansen L; Westerholz S; Wagner KV; Labermaier C; Scharf SH; Santarelli S; Hartmann J; Schmidt MV; Rein T; Müller MB
    Psychoneuroendocrinology; 2014 Oct; 48():98-110. PubMed ID: 24998413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COMMD1 forms oligomeric complexes targeted to the endocytic membranes via specific interactions with phosphatidylinositol 4,5-bisphosphate.
    Burkhead JL; Morgan CT; Shinde U; Haddock G; Lutsenko S
    J Biol Chem; 2009 Jan; 284(1):696-707. PubMed ID: 18940794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Interactions between BM88/Cend1, Ran-binding protein M and Dyrk1B kinase affect cyclin D1 levels and cell cycle progression/exit in mouse neuroblastoma cells.
    Tsioras K; Papastefanaki F; Politis PK; Matsas R; Gaitanou M
    PLoS One; 2013; 8(11):e82172. PubMed ID: 24312406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubules are required for NF-kappaB nuclear translocation in neuroblastoma IMR-32 cells: modulation by zinc.
    Mackenzie GG; Keen CL; Oteiza PI
    J Neurochem; 2006 Oct; 99(2):402-15. PubMed ID: 17029595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT1 is downregulated in gastric cancer and leads to G1-phase arrest via NF-κB/Cyclin D1 signaling.
    Yang Q; Wang B; Gao W; Huang S; Liu Z; Li W; Jia J
    Mol Cancer Res; 2013 Dec; 11(12):1497-507. PubMed ID: 24107295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSCARG regulates NF-kappaB activation by promoting the ubiquitination of RelA or COMMD1.
    Lian M; Zheng X
    J Biol Chem; 2009 Jul; 284(27):17998-8006. PubMed ID: 19433587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway.
    Manu KA; Shanmugam MK; Ramachandran L; Li F; Fong CW; Kumar AP; Tan P; Sethi G
    Clin Cancer Res; 2012 Apr; 18(8):2220-9. PubMed ID: 22351692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.